A virological view of tenascin-C in infection

被引:0
|
作者
Zuliani-Alvarez, Lorena [1 ,2 ,3 ]
Piccinini, Anna M. [4 ]
机构
[1] QBI Coronavirus Res Grp, San Francisco, CA USA
[2] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA USA
[4] Univ Nottingham, Sch Pharm, Nottingham, England
来源
基金
英国惠康基金;
关键词
HIV-1; immune response; SARS-CoV-2; tenascin-C; viral infection; EXTRACELLULAR-MATRIX; IN-VITRO; PROTEIN; FIBRONECTIN; EXPRESSION; IMMUNITY; INFLAMMATION; SARS-COV-2; EXOSOMES; FIBROSIS;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tenascin-C is a large extracellular matrix glycoprotein with complex, not yet fully unveiled roles. Its context- and structure-dependent modus operandi renders tenascin-C a puzzling protein. Since its discovery -40 years ago, research into tenascin-C biology continues to reveal novel functions, the most recent of all being its immunomodulatory activity, especially its role in infection, which is just now beginning to emerge. Here, we explore the role of tenascin-C in the immune response to viruses, including SARS-CoV-2 and HIV-1. Recently, tenascin-C has emerged as a biomarker of disease severity during COVID-19 and other viral infections, and we highlight relevant RNA sequencing and proteomic analyses that suggest a correlation between tenascin-C levels and disease severity. Finally, we ask what the function of this protein during viral replication is and propose tenascin-C as an intercellular signal of inflammation shuttled to distal sites via exosomes, a player in the repair and remodeling of infected and damaged tissues during severe infectious disease, as well as a ligand for specific pathogens with distinct implications for the host.
引用
收藏
页码:C1 / C9
页数:9
相关论文
共 50 条
  • [41] Differential expression of tenascin-C and tenascin-X in human astrocytomas
    Hasegawa, K
    Yoshida, T
    Matsumoto, K
    Katsuta, K
    Waga, S
    Sakakura, T
    ACTA NEUROPATHOLOGICA, 1997, 93 (05) : 431 - 437
  • [42] TENASCIN-C IN PERIPHERAL-NERVE MORPHOGENESIS
    CHIQUET, M
    WEHRLEHALLER, B
    PERSPECTIVES ON DEVELOPMENTAL NEUROBIOLOGY, 1994, 2 (01) : 67 - 74
  • [43] Tenascin-C variants in bullous disease of the cornea
    Maseruka, H
    Ataullah, SM
    Bonshek, RE
    Zardi, L
    JOURNAL OF PATHOLOGY, 1997, 182 : A25 - A25
  • [44] Tenascin-C: a driver of inflammatory bowel disease?
    Ozanne, J.
    Shek, B.
    Milne, E.
    Mclachlan, G.
    Midwood, K.
    Farquharson, C.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2019, 100 (04) : A29 - A30
  • [45] Tenascin-C in primary Merkel cell carcinoma
    Koljonen, V
    Jahkola, T
    Tukiainen, E
    Granroth, G
    Haglund, C
    Böhling, T
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (03) : 297 - 300
  • [46] Tenascin-C isoform expression in colorectal cancer
    Grierson, C
    Holliday, DL
    Jameson, JS
    Pringle, JH
    Jones, JL
    JOURNAL OF PATHOLOGY, 2005, 207 : 39 - 39
  • [47] Immunohistochemical Expression of Tenascin-C in Canine Meningiomas
    de Sant'Ana, Fabiano Jose Ferreira
    Blasco, Ester
    Pumarola, Marti
    VETERINARY SCIENCES, 2024, 11 (10)
  • [48] THE DISTRIBUTION OF TENASCIN-X IS DISTINCT AND OFTEN RECIPROCAL TO THAT OF TENASCIN-C
    MATSUMOTO, K
    SAGA, Y
    IKEMURA, T
    SAKAKURA, T
    CHIQUETEHRISMANN, R
    JOURNAL OF CELL BIOLOGY, 1994, 125 (02): : 483 - 493
  • [49] Tenascin-C: Friend or Foe in Lung Aging?
    Gremlich, Sandrine
    Cremona, Tiziana P.
    Yao, Eveline
    Chabenet, Farah
    Fytianos, Kleanthis
    Roth-Kleiner, Matthias
    Schittny, Johannes C.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [50] Tenascin-C in tendon regions subjected to compression
    Mehr, D
    Pardubsky, PD
    Martin, JA
    Buckwalter, JA
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2000, 18 (04) : 537 - 545